Trial Profile
Single dose study of GS 9256 in patients with genotype 1 hepatitis C
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Feb 2011
Price :
$35
*
At a glance
- Drugs GS 9256 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 16 Feb 2011 Not official study title
- 16 Feb 2011 New trial record